Hospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  2. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain

    AIDS Research and Human Retroviruses, Vol. 28, Núm. 9, pp. 889-894

  3. Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses

    AIDS Research and Human Retroviruses, Vol. 28, Núm. 10, pp. 1259-1261

2010

  1. Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 3018-3020

  2. Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

    AIDS, Vol. 24, Núm. 3, pp. 469-471

2005

  1. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

    Journal of Medical Virology, Vol. 77, Núm. 1, pp. 23-28